Clinical Trials Logo

Filter by:
NCT ID: NCT04427943 Recruiting - Clinical trials for Periprosthetic Knee Infection

Outcome After Revisions of Infected Knee Arthroplasties

RIKA
Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

A prospective multicenter cohort study on all types of revision knee arthroplasty procedures performed due to infection.

NCT ID: NCT04424758 Recruiting - Breast Cancer Clinical Trials

Testing Video Information About Mammography Screening

Start date: June 16, 2020
Phase: N/A
Study type: Interventional

This study examines how video information about mammography screening effect participants knowledge opinions and choice about screening.

NCT ID: NCT04423562 Recruiting - Prognosis Clinical Trials

PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices

PRO-VAD
Start date: April 10, 2020
Phase:
Study type: Observational

Pooling of earlier VO2-studies conducted at the dept. of cardiology, Rigshospitalet, Denmark, and all LVAD centres of the World that wish to participate. The purpose is to investigate the prognostic value of VO2 in recipients of durable LVADs using data from studies already conducted.

NCT ID: NCT04422223 Recruiting - Liver Diseases Clinical Trials

Prospective Cohort Study of Disease and Outcomes in Cirrhosis

ProDoc
Start date: November 1, 2019
Phase:
Study type: Observational [Patient Registry]

A population based incidence cohort will enroll patients newly diagnosed with cirrhosis to investigate disease characteristics and outcomes, explore mechanisms predicting early death and hospital admission, and assess new monitoring tools in treatment and prevention of cirrhosis.

NCT ID: NCT04419259 Recruiting - Rosacea Clinical Trials

Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea

STOP Ros
Start date: June 9, 2020
Phase: Phase 2
Study type: Interventional

An exploratory open-label study of rosacea patients to study the efficacy and tolerability of erenumab in the prophylactic treatment of persistent redness and flushing attributed to rosacea. Approximately 30 subjects will be included in the study and receive erenumab 140 mg for three months. The study will begin June 2020 and is expected to last nine months.

NCT ID: NCT04409119 Recruiting - Heart Failure Clinical Trials

Direct HIS/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB.

HIS-alt_2
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

The study will investigate the feasibility of using direct HIS pacing or left bundle branch pacing (LBB pacing) as an alternative to biventricular pacing in patients with symptomatic heart failure and an ECG with a typical left bundle branch block pattern.

NCT ID: NCT04408885 Recruiting - ACL Injury Clinical Trials

Rehabilitation Treatment of Anterior Cruciate Ligament Rupture

Start date: August 15, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose with this present study is to investigate the effect og a non-surgical regime in patients with an Anterior Cruciate ligament injury. The effect will be measured by patient reported outcome scores, level of function and how many of the patients are converting to operative treatment.

NCT ID: NCT04408755 Recruiting - Clinical trials for Agitation in Patients With Dementia of the Alzheimer's Type

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Start date: July 8, 2020
Phase: Phase 3
Study type: Interventional

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

NCT ID: NCT04408638 Recruiting - Clinical trials for Diffuse Large B-cell Lymphoma

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Start date: February 23, 2021
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of glofitamab in combination with gemcitabine plus oxaliplatin (Glofit-GemOx) compared with rituximab in combination with gemcitabine plus oxaliplatin (R-GemOx) in patients with R/R DLBCL.

NCT ID: NCT04405635 Recruiting - Stroke Clinical Trials

Quantifying Digital Behavior on Smart Phones - Data From Stroke Survivors

QuantStroke
Start date: May 30, 2020
Phase:
Study type: Observational

In this study, we want to continuously record the interaction of 50 stroke survivors with their smartphones during the first 3 months after discharge. The linkage of smart phone use to function and quality of life will be assessed with standardized outcome measures at defined time points.